Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.
Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Stewart ST, Bhatnagar V, Sweeney CJ, Stahl JE, McMahon PM. JAMA. 2010 Dec 1; 304(21):2373-80.